The double role of GABAergic system in systemic tumors: an updated review
Xueyang Yang1, Qianhe Zu2, Luxuan Wang3
1Department of Neurosurgery, Clinical Medicine College, Affiliated Hospital of Hebei University, Hebei University, Baoding, Hebei, China.
Abstract:
The GABAergic system is the main inhibitory nervous system. In addition, GABA has been reported to affect tumor growth and its expression differs between tumor tissue and normal tissue. However, the impact of GABAergic system on tumor progression is context-dependent. The dual potential of the GABAergic system to exert either pro-tumor or anti-tumor effects is fundamentally shaped by the distinct histological features of the neoplasm. The complex components of the GABAergic system and signaling pathways involved might be responsible for this phenomenon. In this study, we reviewed the role of the GABAergic system in promoting or inhibiting tumorigenesis in different organ systems and summarized the possible signaling pathways regulated via GABAA receptor-associated protein (GABARAP). We also discussed the possible role of GABARAP in tumor progression through the regulation of autophagy. Additionally, this study suggest novel therapeutic approach targeting the GABAergic system in the treatment of tumors.
Insights
The GABAergic system
Area of Science:
- Neuroscience
- Oncology
Background:
- The GABAergic system is the primary inhibitory nervous system.
- Gamma-aminobutyric acid (GABA) influences tumor growth, with differing expression in tumor versus normal tissues.
- The effect of the GABAergic system on tumor progression is context-dependent.
Purpose of the Study:
- To review the dual role of the GABAergic system in tumorigenesis across various organ systems.
- To summarize signaling pathways regulated by Gamma-aminobutyric acid A receptor-associated protein (GABARAP).
- To explore GABARAP's role in tumor progression via autophagy regulation and suggest novel therapeutic strategies.
Main Methods:
- Literature review of studies on the GABAergic system and cancer.
- Analysis of signaling pathways involving GABARAP.
- Discussion of GABARAP's role in autophagy and tumor progression.
Main Results:
- The GABAergic system can exhibit both pro-tumor and anti-tumor effects, influenced by neoplasm histology.
- Complex GABAergic components and signaling pathways contribute to this dual role.
- GABARAP is implicated in regulating autophagy, potentially affecting tumor progression.
Conclusions:
- The GABAergic system's impact on tumors is complex and context-dependent.
- GABARAP may represent a therapeutic target for cancer treatment through modulation of autophagy.
- Targeting the GABAergic system offers a potential novel therapeutic approach for tumors.
More Related Videos
12:52Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells
Published on: November 28, 2015
07:39Co-culture of Glutamatergic Neurons and Pediatric High-Grade Glioma Cells Into Microfluidic Devices to Assess Electrical Interactions
Published on: November 17, 2021
Related Concept Videos
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
Antiepileptic Drugs: Glutamate Antagonists
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Enteric Nervous System: Regulation of GI Motor Activity
During periods of fasting, the ENS initiates the migrating myoelectric complex, a...
Aneurysm II: Clinical Manifestations and Diagnostic Studies
